Drug intelligence / Profile preview

Qing Gan An Shen

Development stage: Unknown
Lead developer: Yueyang Hospital of Integrated Traditional Chinese and Western Medicine
Administration: Oral

Overview

Qing Gan An Shen (QGAS) is a Traditional Chinese Medicine (TCM) herbal formulation developed as a granule for the treatment of chronic insomnia. It is primarily developed by the Yueyang Hospital of Integrated Traditional Chinese and Western Medicine and the Shanghai University of Traditional Chinese Medicine. The formulation is designed based on TCM principles to clear liver fire and calm the spirit (An Shen), addressing insomnia symptoms often associated with liver-yang hyperactivity or emotional distress. Clinical evaluation is focused on its efficacy and safety in improving sleep quality and duration in patients with chronic insomnia, typically through randomized, double-blind, placebo-controlled trials.

Other names: Qing Gan An Shen granule

Beyond the preview

Go deeper on Qing Gan An Shen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qing Gan An Shen.

Explore the full profile